Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Banerjee M, Huang Y, Ouseph MM, Joshi S, Pokrovskaya I, Storrie B, et al. Autophagy in Platelets. Methods Mol Biol. 2019;1880:511-528.

McIntire PJ, Snow JT, Elsoukkary SS, Soong L, Sweeney J, Robinson BD, et al. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens. Cancer Cytopathol. 2019;127(2):120-124.

Bartlett NL, Wilson WH, Jung S-, Hsi ED, Maurer MJ, Pederson LD, et al. Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303. J Clin Oncol. 2019;37(21):1790-1799.

Makhni MC, Zhang Y, Park PJ, Cerpa M, Yang M, Pham MH, et al. The "kickstand rod" technique for correction of coronal imbalance in patients with adult spinal deformity: initial case series. J Neurosurg Spine. 2019:1-8.

Fernandez EM, Eng K, Beg S, Beltran H, Faltas BM, Mosquera JM, et al. Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution. JCO Precis Oncol. 2019;3.

Solomon JP, Benayed R, Hechtman JF, Ladanyi M. Identifying patients with NTRK fusion cancer. Ann Oncol. 2019;30 Suppl 8:viii16-viii22.

Vossoughi S, Gorlin J, Kessler DA, Hillyer CD, Van Buren NL, Jimenez A, et al. Ten years of TRALI mitigation: measuring our progress. Transfusion. 2019;59(8):2567-2574.

Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, et al. MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma. J Neuroimaging. 2019;29(3):357-363.

Ji G, Xu R, Niu Y, Li N, Ivashkiv L, Bostrom MP, et al. Vascular endothelial growth factor pathway promotes osseointegration and CD31EMCN endothelium expansion in a mouse tibial implant model: an animal study. Bone Joint J. 2019;101-B(7_Supple_C):108-114.

Patel SS, Weirather JL, Lipschitz M, Lako A, Chen P-, Griffin GK, et al. The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negative. Blood. 2019;134(23):2059-2069.